Channel Therapeutics Corp
CHRO1.350USD
+0.090+7.14%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
8.35MMarket Cap
LossP/E TTM
Channel Therapeutics Corp
1.350
+0.090+7.14%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
68.27%-632.13K
-87.85%-670.26K
30.84%-177.91K
-1424.85%-2.95M
-1048.93%-1.99M
46.48%-356.81K
0.22%-257.24K
33.56%-193.62K
50.65%-173.37K
-114.48%-666.62K
63.36%-257.79K
---291.41K
---351.33K
---310.81K
---703.60K
Net income from continuing operations
23.21%-1.97M
52.30%-1.93M
-19.20%-1.69M
-85.83%-1.77M
-165.10%-2.56M
-446.13%-4.04M
-32.32%-1.42M
-185.39%-953.35K
-211.34%-966.56K
-252.24%-739.59K
-483.12%-1.07M
---334.06K
---310.45K
---209.97K
---184.26K
Operating gains losses
----
----
----
----
----
----
----
----
----
----
--517.84K
----
----
----
----
Other non-cash items
-83.17%94.21K
-37.29%76.09K
-478.27%-352.79K
-100.00%0.00
1668.86%559.84K
125.53%121.33K
146.65%93.26K
283.60%143.47K
40.01%31.65K
---475.23K
--37.81K
--37.40K
--22.61K
----
--0.00
Change in working capital
367.93%755.44K
19.47%649.96K
85.54%1.35M
-667.56%-1.64M
-157.62%-281.96K
24.19%544.04K
179.18%728.80K
5406.33%288.92K
870.74%489.32K
534.39%438.05K
150.27%261.05K
--5.25K
---63.49K
---100.84K
---519.33K
-Change in prepaid expenses
122.16%48.96K
--29.29K
--63.52K
--62.83K
---220.93K
----
----
----
----
----
----
----
----
----
----
-Change in payables and accrued expense
676.40%706.48K
34.96%620.98K
229.58%2.04M
-968.71%-1.57M
-75.23%90.99K
38.90%460.13K
1413.28%618.58K
2142.52%180.97K
1000.31%367.33K
428.50%331.27K
105.62%40.88K
--8.07K
--33.38K
---100.84K
---726.86K
-Change in other current assets
----
--0.00
---750.00K
----
----
----
----
100.00%0.00
100.00%0.00
----
-51.96%99.69K
---2.82K
---96.87K
--0.00
--207.53K
Cash from non-recurring investing activities
Cash from operating activities
68.27%-632.13K
-87.85%-670.26K
30.84%-177.91K
-1424.85%-2.95M
-1048.93%-1.99M
46.48%-356.81K
0.22%-257.24K
33.56%-193.62K
50.65%-173.37K
-114.48%-666.62K
63.36%-257.79K
---291.41K
---351.33K
---310.81K
---703.60K
Investing cash flow
Cash from non-current investing activities
Financing cash flow
Cash flow from continuous financing activities
-95.59%250.00K
-116.54%-71.20K
-590.74%-972.28K
599.54%1.59M
3294.63%5.67M
-21.52%430.41K
-53.78%198.13K
-22.77%226.91K
-52.49%166.90K
76.46%548.45K
-39.08%428.64K
--293.80K
--351.33K
--310.81K
--703.60K
Net cash flow from debt Issuance/repayment
216.41%250.00K
-126.25%-153.82K
-552.88%-897.28K
599.54%1.59M
-228.67%-214.76K
485.93%585.93K
--198.13K
--226.91K
-44.37%166.90K
--100.00K
--0.00
--0.00
--300.00K
--0.00
--0.00
Net cash flow from common stock issuance/repurchase
----
-67.65%82.62K
---75.00K
--0.00
--5.88M
--255.41K
----
----
----
----
----
----
----
----
----
Net cash flow from other financing activities
----
----
----
----
----
-191.63%-410.93K
----
----
-100.00%0.00
44.28%448.45K
-39.08%428.64K
--293.80K
--51.33K
--310.81K
--703.60K
Net cash from non-recurrent financing activities
Net cash from financing activities
-95.59%250.00K
-116.54%-71.20K
-590.74%-972.28K
599.54%1.59M
3294.63%5.67M
-21.52%430.41K
-53.78%198.13K
-22.77%226.91K
-52.49%166.90K
76.46%548.45K
-39.08%428.64K
--293.80K
--351.33K
--310.81K
--703.60K
Net cash flow
Beginning cash balance
432.67%513.44K
5407.34%1.25M
2836.88%2.41M
7656.40%3.77M
75.02%96.39K
-86.85%22.79K
3330.79%81.89K
--48.61K
--55.07K
--173.24K
--2.39K
--0.00
--0.00
--0.00
--0.00
Current period cash flow changes
-110.40%-382.13K
-1107.35%-741.46K
-1845.95%-1.15M
-4201.34%-1.37M
56917.79%3.67M
162.29%73.61K
-134.60%-59.11K
1294.43%33.28K
---6.47K
---118.17K
--170.85K
--2.39K
--0.00
--0.00
--0.00
Ending cash balance
-96.52%131.32K
432.67%513.44K
5407.34%1.25M
2836.88%2.41M
7656.40%3.77M
75.02%96.39K
-86.85%22.79K
3330.79%81.89K
--48.61K
--55.07K
--173.24K
--2.39K
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
